nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexmedetomidine—Hypovolaemia—Furosemide—dilated cardiomyopathy	0.0332	0.0574	CcSEcCtD
Dexmedetomidine—Infarction—Lisinopril—dilated cardiomyopathy	0.0278	0.0481	CcSEcCtD
Dexmedetomidine—Metabolic acidosis—Furosemide—dilated cardiomyopathy	0.026	0.045	CcSEcCtD
Dexmedetomidine—Hyperkalaemia—Spironolactone—dilated cardiomyopathy	0.0186	0.0321	CcSEcCtD
Dexmedetomidine—Hypomagnesaemia—Furosemide—dilated cardiomyopathy	0.0162	0.028	CcSEcCtD
Dexmedetomidine—Renal failure acute—Spironolactone—dilated cardiomyopathy	0.0149	0.0257	CcSEcCtD
Dexmedetomidine—Generalised oedema—Lisinopril—dilated cardiomyopathy	0.013	0.0224	CcSEcCtD
Dexmedetomidine—Fluid overload—Lisinopril—dilated cardiomyopathy	0.0124	0.0215	CcSEcCtD
Dexmedetomidine—Hypocalcaemia—Furosemide—dilated cardiomyopathy	0.0112	0.0194	CcSEcCtD
Dexmedetomidine—Pleural effusion—Lisinopril—dilated cardiomyopathy	0.0101	0.0174	CcSEcCtD
Dexmedetomidine—Oliguria—Lisinopril—dilated cardiomyopathy	0.00837	0.0145	CcSEcCtD
Dexmedetomidine—Leukocytosis—Lisinopril—dilated cardiomyopathy	0.00821	0.0142	CcSEcCtD
Dexmedetomidine—Thirst—Furosemide—dilated cardiomyopathy	0.00784	0.0136	CcSEcCtD
Dexmedetomidine—Ventricular tachycardia—Lisinopril—dilated cardiomyopathy	0.00771	0.0133	CcSEcCtD
Dexmedetomidine—Hyperkalaemia—Lisinopril—dilated cardiomyopathy	0.00758	0.0131	CcSEcCtD
Dexmedetomidine—Wheezing—Lisinopril—dilated cardiomyopathy	0.00749	0.013	CcSEcCtD
Dexmedetomidine—Fluid retention—Lisinopril—dilated cardiomyopathy	0.00732	0.0127	CcSEcCtD
Dexmedetomidine—Blood urea increased—Lisinopril—dilated cardiomyopathy	0.00728	0.0126	CcSEcCtD
Dexmedetomidine—Pulmonary oedema—Lisinopril—dilated cardiomyopathy	0.00687	0.0119	CcSEcCtD
Dexmedetomidine—Confusional state—Spironolactone—dilated cardiomyopathy	0.0068	0.0118	CcSEcCtD
Dexmedetomidine—Hypokalaemia—Furosemide—dilated cardiomyopathy	0.00679	0.0117	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.0066	0.0114	CcSEcCtD
Dexmedetomidine—Abdominal distension—Furosemide—dilated cardiomyopathy	0.00649	0.0112	CcSEcCtD
Dexmedetomidine—Hepatic function abnormal—Lisinopril—dilated cardiomyopathy	0.00641	0.0111	CcSEcCtD
Dexmedetomidine—Renal failure acute—Lisinopril—dilated cardiomyopathy	0.00607	0.0105	CcSEcCtD
Dexmedetomidine—Somnolence—Spironolactone—dilated cardiomyopathy	0.00599	0.0104	CcSEcCtD
Dexmedetomidine—Atrial fibrillation—Lisinopril—dilated cardiomyopathy	0.00591	0.0102	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00582	0.0101	CcSEcCtD
Dexmedetomidine—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.00582	0.0101	CcSEcCtD
Dexmedetomidine—Hypoglycaemia—Lisinopril—dilated cardiomyopathy	0.00574	0.00993	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00556	0.00961	CcSEcCtD
Dexmedetomidine—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00533	0.00922	CcSEcCtD
Dexmedetomidine—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.00532	0.00921	CcSEcCtD
Dexmedetomidine—Visual impairment—Furosemide—dilated cardiomyopathy	0.00498	0.00861	CcSEcCtD
Dexmedetomidine—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.00476	0.00824	CcSEcCtD
Dexmedetomidine—Sweating increased—Lisinopril—dilated cardiomyopathy	0.00471	0.00816	CcSEcCtD
Dexmedetomidine—Angiopathy—Furosemide—dilated cardiomyopathy	0.00468	0.0081	CcSEcCtD
Dexmedetomidine—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00461	0.00798	CcSEcCtD
Dexmedetomidine—Arrhythmia—Furosemide—dilated cardiomyopathy	0.00461	0.00798	CcSEcCtD
Dexmedetomidine—Malnutrition—Furosemide—dilated cardiomyopathy	0.00449	0.00778	CcSEcCtD
Dexmedetomidine—Dizziness—Spironolactone—dilated cardiomyopathy	0.00446	0.00771	CcSEcCtD
Dexmedetomidine—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.00437	0.00755	CcSEcCtD
Dexmedetomidine—Pneumonia—Lisinopril—dilated cardiomyopathy	0.00434	0.00751	CcSEcCtD
Dexmedetomidine—Vomiting—Spironolactone—dilated cardiomyopathy	0.00429	0.00742	CcSEcCtD
Dexmedetomidine—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.00425	0.00736	CcSEcCtD
Dexmedetomidine—Rash—Spironolactone—dilated cardiomyopathy	0.00425	0.00735	CcSEcCtD
Dexmedetomidine—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00425	0.00735	CcSEcCtD
Dexmedetomidine—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.00423	0.00732	CcSEcCtD
Dexmedetomidine—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.00423	0.00732	CcSEcCtD
Dexmedetomidine—Headache—Spironolactone—dilated cardiomyopathy	0.00422	0.00731	CcSEcCtD
Dexmedetomidine—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.00419	0.00726	CcSEcCtD
Dexmedetomidine—Anaemia—Furosemide—dilated cardiomyopathy	0.00415	0.00719	CcSEcCtD
Dexmedetomidine—Agitation—Furosemide—dilated cardiomyopathy	0.00413	0.00715	CcSEcCtD
Dexmedetomidine—Nausea—Spironolactone—dilated cardiomyopathy	0.004	0.00693	CcSEcCtD
Dexmedetomidine—Bradycardia—Lisinopril—dilated cardiomyopathy	0.00394	0.00682	CcSEcCtD
Dexmedetomidine—Hallucination—Lisinopril—dilated cardiomyopathy	0.00385	0.00667	CcSEcCtD
Dexmedetomidine—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.00382	0.0066	CcSEcCtD
Dexmedetomidine—Dry mouth—Furosemide—dilated cardiomyopathy	0.00374	0.00647	CcSEcCtD
Dexmedetomidine—Confusional state—Furosemide—dilated cardiomyopathy	0.0037	0.0064	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00359	0.00621	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00355	0.00613	CcSEcCtD
Dexmedetomidine—Angiopathy—Lisinopril—dilated cardiomyopathy	0.00351	0.00608	CcSEcCtD
Dexmedetomidine—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.00349	0.00604	CcSEcCtD
Dexmedetomidine—Chills—Lisinopril—dilated cardiomyopathy	0.00348	0.00601	CcSEcCtD
Dexmedetomidine—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.00346	0.00599	CcSEcCtD
Dexmedetomidine—Hypotension—Furosemide—dilated cardiomyopathy	0.00343	0.00593	CcSEcCtD
Dexmedetomidine—Mental disorder—Lisinopril—dilated cardiomyopathy	0.00339	0.00587	CcSEcCtD
Dexmedetomidine—Malnutrition—Lisinopril—dilated cardiomyopathy	0.00337	0.00583	CcSEcCtD
Dexmedetomidine—Somnolence—Furosemide—dilated cardiomyopathy	0.00326	0.00564	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00317	0.00548	CcSEcCtD
Dexmedetomidine—Pain—Furosemide—dilated cardiomyopathy	0.00314	0.00543	CcSEcCtD
Dexmedetomidine—Constipation—Furosemide—dilated cardiomyopathy	0.00314	0.00543	CcSEcCtD
Dexmedetomidine—Anaemia—Lisinopril—dilated cardiomyopathy	0.00312	0.00539	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00302	0.00523	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.003	0.00519	CcSEcCtD
Dexmedetomidine—Body temperature increased—Furosemide—dilated cardiomyopathy	0.0029	0.00502	CcSEcCtD
Dexmedetomidine—Abdominal pain—Furosemide—dilated cardiomyopathy	0.0029	0.00502	CcSEcCtD
Dexmedetomidine—Anxiety—Lisinopril—dilated cardiomyopathy	0.00286	0.00495	CcSEcCtD
Dexmedetomidine—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00281	0.00486	CcSEcCtD
Dexmedetomidine—Confusional state—Lisinopril—dilated cardiomyopathy	0.00278	0.0048	CcSEcCtD
Dexmedetomidine—Infection—Lisinopril—dilated cardiomyopathy	0.00273	0.00473	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.00269	0.00466	CcSEcCtD
Dexmedetomidine—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00269	0.00465	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00266	0.0046	CcSEcCtD
Dexmedetomidine—Hypotension—Lisinopril—dilated cardiomyopathy	0.00257	0.00445	CcSEcCtD
Dexmedetomidine—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00251	0.00434	CcSEcCtD
Dexmedetomidine—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00245	0.00424	CcSEcCtD
Dexmedetomidine—Somnolence—Lisinopril—dilated cardiomyopathy	0.00245	0.00423	CcSEcCtD
Dexmedetomidine—Dizziness—Furosemide—dilated cardiomyopathy	0.00243	0.0042	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.00238	0.00411	CcSEcCtD
Dexmedetomidine—Constipation—Lisinopril—dilated cardiomyopathy	0.00235	0.00407	CcSEcCtD
Dexmedetomidine—Pain—Lisinopril—dilated cardiomyopathy	0.00235	0.00407	CcSEcCtD
Dexmedetomidine—Vomiting—Furosemide—dilated cardiomyopathy	0.00233	0.00403	CcSEcCtD
Dexmedetomidine—Rash—Furosemide—dilated cardiomyopathy	0.00231	0.004	CcSEcCtD
Dexmedetomidine—Dermatitis—Furosemide—dilated cardiomyopathy	0.00231	0.004	CcSEcCtD
Dexmedetomidine—Headache—Furosemide—dilated cardiomyopathy	0.0023	0.00398	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00227	0.00392	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00225	0.00389	CcSEcCtD
Dexmedetomidine—Nausea—Furosemide—dilated cardiomyopathy	0.00218	0.00377	CcSEcCtD
Dexmedetomidine—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00218	0.00376	CcSEcCtD
Dexmedetomidine—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00218	0.00376	CcSEcCtD
Dexmedetomidine—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00188	0.00326	CcSEcCtD
Dexmedetomidine—Dizziness—Lisinopril—dilated cardiomyopathy	0.00182	0.00315	CcSEcCtD
Dexmedetomidine—Vomiting—Lisinopril—dilated cardiomyopathy	0.00175	0.00303	CcSEcCtD
Dexmedetomidine—Rash—Lisinopril—dilated cardiomyopathy	0.00174	0.003	CcSEcCtD
Dexmedetomidine—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00173	0.003	CcSEcCtD
Dexmedetomidine—Headache—Lisinopril—dilated cardiomyopathy	0.00172	0.00298	CcSEcCtD
Dexmedetomidine—Nausea—Lisinopril—dilated cardiomyopathy	0.00163	0.00283	CcSEcCtD
Dexmedetomidine—ADRA1D—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000536	0.00127	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Metabolism—TAZ—dilated cardiomyopathy	0.000535	0.00127	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000533	0.00126	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000529	0.00125	CbGpPWpGaD
Dexmedetomidine—ADRA2C—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000525	0.00124	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00052	0.00123	CbGpPWpGaD
Dexmedetomidine—ADRA1D—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000508	0.0012	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—dilated cardiomyopathy	0.000507	0.0012	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	0.000497	0.00118	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000495	0.00117	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Metabolism—SDHA—dilated cardiomyopathy	0.000484	0.00115	CbGpPWpGaD
Dexmedetomidine—ADRA2B—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000484	0.00115	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000482	0.00114	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000477	0.00113	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000477	0.00113	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	0.000469	0.00111	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.000464	0.0011	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—ANKRD1—dilated cardiomyopathy	0.000462	0.0011	CbGpPWpGaD
Dexmedetomidine—ADRA2B—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000459	0.00109	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000457	0.00108	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—dilated cardiomyopathy	0.000457	0.00108	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000452	0.00107	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000447	0.00106	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000445	0.00105	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000444	0.00105	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—TAZ—dilated cardiomyopathy	0.000434	0.00103	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00043	0.00102	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000428	0.00102	CbGpPWpGaD
Dexmedetomidine—ADRA2A—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000426	0.00101	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—ANKRD1—dilated cardiomyopathy	0.000424	0.00101	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000422	0.001	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000417	0.000989	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	0.000413	0.000979	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	0.000413	0.000979	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000411	0.000974	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	0.00041	0.000971	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—ANKRD1—dilated cardiomyopathy	0.0004	0.000948	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—TAZ—dilated cardiomyopathy	0.000399	0.000946	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Hemostasis—ITGB1—dilated cardiomyopathy	0.000396	0.000939	CbGpPWpGaD
Dexmedetomidine—ADRA1D—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000394	0.000933	CbGpPWpGaD
Dexmedetomidine—ADRA1D—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000394	0.000933	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	0.000393	0.000932	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	0.000393	0.000932	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—SDHA—dilated cardiomyopathy	0.000393	0.000931	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.000385	0.000912	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	0.000383	0.000907	CbGpPWpGaD
Dexmedetomidine—ADRA1D—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000377	0.000893	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—TAZ—dilated cardiomyopathy	0.000376	0.000892	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Hemostasis—ITGB1—dilated cardiomyopathy	0.00037	0.000877	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000367	0.00087	CbGpPWpGaD
Dexmedetomidine—ADRA1D—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000366	0.000867	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—SDHA—dilated cardiomyopathy	0.000361	0.000855	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000357	0.000847	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000357	0.000847	CbGpPWpGaD
Dexmedetomidine—ADRA2B—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000355	0.000842	CbGpPWpGaD
Dexmedetomidine—ADRA2B—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000355	0.000842	CbGpPWpGaD
Dexmedetomidine—ADRA1D—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000354	0.00084	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000348	0.000825	CbGpPWpGaD
Dexmedetomidine—ADRA2B—GPCR ligand binding—AGT—dilated cardiomyopathy	0.00034	0.000806	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—SDHA—dilated cardiomyopathy	0.00034	0.000806	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000339	0.000803	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Hemostasis—CD36—dilated cardiomyopathy	0.000338	0.000801	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000332	0.000788	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000332	0.000787	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000332	0.000787	CbGpPWpGaD
Dexmedetomidine—ADRA2B—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.00033	0.000783	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000327	0.000774	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000327	0.000774	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000323	0.000765	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000323	0.000765	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000322	0.000763	CbGpPWpGaD
Dexmedetomidine—ADRA2B—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.00032	0.000758	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Hemostasis—RAC1—dilated cardiomyopathy	0.000318	0.000755	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000318	0.000754	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000318	0.000753	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Hemostasis—CD36—dilated cardiomyopathy	0.000316	0.000748	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000313	0.000741	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	0.000311	0.000737	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000309	0.000731	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000304	0.00072	CbGpPWpGaD
Dexmedetomidine—ADRA1D—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000303	0.000717	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000301	0.000714	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000301	0.000714	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—ANKRD1—dilated cardiomyopathy	0.000301	0.000714	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Hemostasis—ITGB1—dilated cardiomyopathy	0.000301	0.000712	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.0003	0.000711	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000299	0.000708	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Hemostasis—RAC1—dilated cardiomyopathy	0.000297	0.000705	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000297	0.000703	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000297	0.000703	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000294	0.000697	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000291	0.000689	CbGpPWpGaD
Dexmedetomidine—ADRA1D—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000287	0.000681	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—TAZ—dilated cardiomyopathy	0.000283	0.000671	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.00028	0.000664	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000276	0.000654	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000275	0.000651	CbGpPWpGaD
Dexmedetomidine—ADRA2B—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000273	0.000648	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000271	0.000643	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.00027	0.000639	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.00027	0.000639	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000267	0.000633	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000264	0.000626	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000261	0.000618	CbGpPWpGaD
Dexmedetomidine—ADRA2B—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000259	0.000614	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000258	0.000612	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Hemostasis—CD36—dilated cardiomyopathy	0.000256	0.000608	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—SDHA—dilated cardiomyopathy	0.000256	0.000607	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000255	0.000605	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—ANKRD1—dilated cardiomyopathy	0.000255	0.000605	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000251	0.000595	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000251	0.000594	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000248	0.000588	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000245	0.00058	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000245	0.00058	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000243	0.000575	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000242	0.000574	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Hemostasis—RAC1—dilated cardiomyopathy	0.000242	0.000573	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—TAZ—dilated cardiomyopathy	0.00024	0.000568	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000238	0.000565	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000238	0.000564	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000235	0.000558	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000232	0.000549	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000228	0.000541	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000228	0.000539	CbGpPWpGaD
Dexmedetomidine—ADRA1D—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000223	0.000528	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.00022	0.000522	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.00022	0.000521	CbGpPWpGaD
Dexmedetomidine—SLC6A2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000218	0.000516	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—SDHA—dilated cardiomyopathy	0.000217	0.000514	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000216	0.000513	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000215	0.000509	CbGpPWpGaD
Dexmedetomidine—ADRA1D—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000213	0.000505	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Hemostasis—RAF1—dilated cardiomyopathy	0.000211	0.0005	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000211	0.0005	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000211	0.0005	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000208	0.000492	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000207	0.000491	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000202	0.00048	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000202	0.000479	CbGpPWpGaD
Dexmedetomidine—ADRA2B—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000201	0.000477	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000201	0.000475	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000197	0.000468	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Hemostasis—RAF1—dilated cardiomyopathy	0.000197	0.000467	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000197	0.000466	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000196	0.000465	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000193	0.000458	CbGpPWpGaD
Dexmedetomidine—ADRA2B—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000192	0.000456	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000191	0.000452	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000191	0.000452	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.00019	0.000451	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000188	0.000446	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000188	0.000446	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000185	0.000439	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000183	0.000433	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000182	0.000431	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.00018	0.000426	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000179	0.000423	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000178	0.000422	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000178	0.000422	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000177	0.00042	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000177	0.000419	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000175	0.000415	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000175	0.000415	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000175	0.000414	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000172	0.000407	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000171	0.000405	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000168	0.000398	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000166	0.000392	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000163	0.000387	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000163	0.000386	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000163	0.000386	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000162	0.000385	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000161	0.00038	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.00016	0.00038	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Hemostasis—RAF1—dilated cardiomyopathy	0.00016	0.00038	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000158	0.000374	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000154	0.000365	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000153	0.000362	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000147	0.000347	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000146	0.000346	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000145	0.000343	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000145	0.000343	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000139	0.00033	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000139	0.000329	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000137	0.000325	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000135	0.000319	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000134	0.000319	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000134	0.000318	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000132	0.000314	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000132	0.000314	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000132	0.000314	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Metabolism—GPX1—dilated cardiomyopathy	0.000131	0.000311	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.00013	0.000309	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.00013	0.000308	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000129	0.000305	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Metabolism—CD36—dilated cardiomyopathy	0.000128	0.000303	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000128	0.000303	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000121	0.000287	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—RAC1—dilated cardiomyopathy	0.00012	0.000283	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000119	0.000283	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000116	0.000275	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Metabolism—AGT—dilated cardiomyopathy	0.000115	0.000273	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—AGT—dilated cardiomyopathy	0.000114	0.000271	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000113	0.000268	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000112	0.000265	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000111	0.000264	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000111	0.000264	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.00011	0.00026	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000108	0.000256	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—GPX1—dilated cardiomyopathy	0.000107	0.000253	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000106	0.00025	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—CD36—dilated cardiomyopathy	0.000104	0.000246	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—AGT—dilated cardiomyopathy	0.000103	0.000244	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000101	0.000239	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—RAC1—dilated cardiomyopathy	9.93e-05	0.000235	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—GPX1—dilated cardiomyopathy	9.8e-05	0.000232	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—AGT—dilated cardiomyopathy	9.64e-05	0.000228	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—CD36—dilated cardiomyopathy	9.55e-05	0.000226	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—AGT—dilated cardiomyopathy	9.48e-05	0.000225	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—AGT—dilated cardiomyopathy	9.36e-05	0.000222	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—GPX1—dilated cardiomyopathy	9.24e-05	0.000219	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—EGFR—dilated cardiomyopathy	9.2e-05	0.000218	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—RAF1—dilated cardiomyopathy	9.19e-05	0.000218	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	9.07e-05	0.000215	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—CD36—dilated cardiomyopathy	9e-05	0.000213	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—AGT—dilated cardiomyopathy	8.59e-05	0.000204	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—EGFR—dilated cardiomyopathy	8.31e-05	0.000197	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—RAC1—dilated cardiomyopathy	8.19e-05	0.000194	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—AGT—dilated cardiomyopathy	8.1e-05	0.000192	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—RAF1—dilated cardiomyopathy	7.93e-05	0.000188	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—AGT—dilated cardiomyopathy	7.83e-05	0.000185	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—EGFR—dilated cardiomyopathy	7.76e-05	0.000184	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—EGFR—dilated cardiomyopathy	7.64e-05	0.000181	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—RAF1—dilated cardiomyopathy	7.16e-05	0.00017	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	6.96e-05	0.000165	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	6.77e-05	0.000161	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—RAF1—dilated cardiomyopathy	6.69e-05	0.000158	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—RAF1—dilated cardiomyopathy	6.58e-05	0.000156	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—EGFR—dilated cardiomyopathy	6.31e-05	0.000149	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	6.1e-05	0.000145	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—GPX1—dilated cardiomyopathy	5.89e-05	0.00014	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—CD36—dilated cardiomyopathy	5.74e-05	0.000136	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—EGFR—dilated cardiomyopathy	5.44e-05	0.000129	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—RAF1—dilated cardiomyopathy	5.43e-05	0.000129	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—AGT—dilated cardiomyopathy	5.17e-05	0.000122	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—EGFR—dilated cardiomyopathy	4.91e-05	0.000116	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—EGFR—dilated cardiomyopathy	4.59e-05	0.000109	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—EGFR—dilated cardiomyopathy	4.51e-05	0.000107	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—EGFR—dilated cardiomyopathy	3.72e-05	8.83e-05	CbGpPWpGaD
